Literature DB >> 17929067

Simultaneous dynamic T1 and T2* measurement for AIF assessment combined with DCE MRI in a mouse tumor model.

Melanie Heilmann1, Christine Walczak, Julien Vautier, Jean-Luc Dimicoli, Carole D Thomas, Mihaela Lupu, Joël Mispelter, Andreas Volk.   

Abstract

A double-delay SR-MGE-SNAP sequence allowing simultaneous T1 and T2* measurement was developed for integrating arterial input function (AIF) measurement into DCE MRI. Implemented on a 4.7-T animal MR system, this technique was applied to mice with colorectal tumor xenografts. AIF, measured in the mouse heart, was modeled by a bi-exponential function, whereas tumor K(trans) and v(e) parameter maps were obtained from analysis with a two- compartment model using an individually measured AIF. AIF analysis of T2*-corrected data yielded A1 = 9.2 +/- 4.3 kg/l, A(2) = 4.2 +/- 0.8 kg/l, m1 = 2.3 +/- 1.1 min(-1), and m2 = 0.05 +/- 0.02 min(-1). The mean initial plasma concentration C ( p )(t = 0) = 8.0 +/- 2.7 mM was compatible with estimated 8.6 mM. Without T2*-correction distribution phase parameters A1, m1, and C(p)(t = 0) were underestimated. In tumors, neglect of T2* effects yielded mean K(trans) values which were reduced by 14% (P < 0.05), whereas v(e) showed only a slight non-significant reduction. Simultaneous measurement of DeltaR1 and DeltaR2* studied in highly and poorly vascularized and (pre-)necrotic tumor regions revealed complementary behavior of both parameters with respect to vascular properties. In conclusion, the presented measurement technique is a promising tool for dynamic MRI applications studied in animal models at high field strengths and/or with CA of high relaxivities, as it combines classical DCE MRI integrating AIF assessment with dynamic T2* measurement.

Entities:  

Mesh:

Year:  2007        PMID: 17929067     DOI: 10.1007/s10334-007-0082-2

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  21 in total

1.  Simultaneous quantitative cerebral perfusion and Gd-DTPA extravasation measurement with dual-echo dynamic susceptibility contrast MRI.

Authors:  E P Vonken; M J van Osch; C J Bakker; M A Viergever
Journal:  Magn Reson Med       Date:  2000-06       Impact factor: 4.668

2.  Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies.

Authors:  Caleb Roberts; Basma Issa; Andrew Stone; Alan Jackson; John C Waterton; Geoffrey J M Parker
Journal:  J Magn Reson Imaging       Date:  2006-04       Impact factor: 4.813

3.  Implementation of a rapid inversion-prepared dual-contrast gradient echo sequence for quantitative dynamic contrast-enhanced magnetic resonance imaging of the human prostate.

Authors:  Daniel Prochnow; Dirk Beyersdorff; Carsten Warmuth; Matthias Taupitz; Ole Gemeinhardt; Lutz Lüdemann
Journal:  Magn Reson Imaging       Date:  2005-12       Impact factor: 2.546

4.  Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.

Authors:  Z M Bhujwalla; D Artemov; K Natarajan; E Ackerstaff; M Solaiyappan
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

5.  Combined T2* and T1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement.

Authors:  Cedric de Bazelaire; Neil M Rofsky; Guillaume Duhamel; Jingbo Zhang; M Dror Michaelson; Daniel George; David C Alsop
Journal:  Eur Radiol       Date:  2006-04-01       Impact factor: 5.315

6.  Novel system for determining contrast agent concentration in mouse blood in vivo.

Authors:  Arvind P Pathak; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Magn Reson Med       Date:  2004-03       Impact factor: 4.668

7.  MRI estimation of the arterial input function in mice.

Authors:  Stephen Pickup; Rong Zhou; Jerry Glickson
Journal:  Acad Radiol       Date:  2003-09       Impact factor: 3.173

8.  Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: effects of transcytolemmal water exchange.

Authors:  Rong Zhou; Stephen Pickup; Thomas E Yankeelov; Charles S Springer; Jerry D Glickson
Journal:  Magn Reson Med       Date:  2004-08       Impact factor: 4.668

9.  Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.

Authors:  Karl Turetschek; Anda Preda; Viktor Novikov; Robert C Brasch; Hanns J Weinmann; Patrick Wunderbaldinger; Timothy P L Roberts
Journal:  J Magn Reson Imaging       Date:  2004-07       Impact factor: 4.813

Review 10.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

View more
  9 in total

1.  High-resolution magnetic resonance colonography and dynamic contrast-enhanced magnetic resonance imaging in a murine model of colitis.

Authors:  Devkumar Mustafi; Xiaobing Fan; Urszula Dougherty; Marc Bissonnette; Gregory S Karczmar; Aytekin Oto; John Hart; Erica Markiewicz; Marta Zamora
Journal:  Magn Reson Med       Date:  2010-04       Impact factor: 4.668

2.  Sensitivity analysis of an image-based solid tumor computational model with heterogeneous vasculature and porosity.

Authors:  Gregory L Pishko; Garrett W Astary; Thomas H Mareci; Malisa Sarntinoranont
Journal:  Ann Biomed Eng       Date:  2011-07-13       Impact factor: 3.934

3.  Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer.

Authors:  Stephanie L Barnes; Jennifer G Whisenant; Mary E Loveless; Gregory D Ayers; Thomas E Yankeelov
Journal:  Magn Reson Med       Date:  2012-07-27       Impact factor: 4.668

4.  Use of cardiac output to improve measurement of input function in quantitative dynamic contrast-enhanced MRI.

Authors:  Jeff L Zhang; Henry Rusinek; Louisa Bokacheva; Qun Chen; Pippa Storey; Vivian S Lee
Journal:  J Magn Reson Imaging       Date:  2009-09       Impact factor: 4.813

5.  High-spatial- and high-temporal-resolution dynamic contrast-enhanced MR breast imaging with sweep imaging with Fourier transformation: a pilot study.

Authors:  Curtis A Corum; John C Benson; Djaudat Idiyatullin; Angela L Snyder; Carl J Snyder; Diane Hutter; Lenore I Everson; Lynn E Eberly; Michael T Nelson; Michael Garwood
Journal:  Radiology       Date:  2014-09-22       Impact factor: 11.105

6.  Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect.

Authors:  Esther A Kleibeuker; Emmanouil Fokas; Philip D Allen; Veerle Kersemans; Arjan W Griffioen; John Beech; Jaehong H Im; Sean C Smart; Kitty C Castricum; Jaap van den Berg; Iris A Schulkens; Sally A Hill; Adrian L Harris; Ben J Slotman; Henk M Verheul; Ruth J Muschel; Victor L Thijssen
Journal:  Oncotarget       Date:  2016-11-22

7.  Simultaneous multislice acquisition with multi-contrast segmented EPI for separation of signal contributions in dynamic contrast-enhanced imaging.

Authors:  Klaus Eickel; David Andrew Porter; Anika Söhner; Marc Maaß; Lutz Lüdemann; Matthias Günther
Journal:  PLoS One       Date:  2018-08-28       Impact factor: 3.240

8.  R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T.

Authors:  Jana Kim; Siver A Moestue; Tone F Bathen; Eugene Kim
Journal:  Tomography       Date:  2019-09

9.  Functional Parameters Derived from Magnetic Resonance Imaging Reflect Vascular Morphology in Preclinical Tumors and in Human Liver Metastases.

Authors:  Pavitra Kannan; Warren W Kretzschmar; Helen Winter; Daniel Warren; Russell Bates; Philip D Allen; Nigar Syed; Benjamin Irving; Bartlomiej W Papiez; Jakob Kaeppler; Bosjtan Markelc; Paul Kinchesh; Stuart Gilchrist; Sean Smart; Julia A Schnabel; Tim Maughan; Adrian L Harris; Ruth J Muschel; Mike Partridge; Ricky A Sharma; Veerle Kersemans
Journal:  Clin Cancer Res       Date:  2018-06-29       Impact factor: 12.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.